Compare BioNano Genomics Inc (BNGO) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.20M), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $27.57. The key difference: ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | KOLD | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.92 | $49.39 |
52-Week Low | $1.09 | $13.58 |
Enterprise Value | $15.81M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
KOLD, the ProShares UltraShort Bloomberg Natural Gas ETF, trades at $27.98, up 3.78% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest overbought conditions. Recent news highlights volatility in natural gas futures driven by weather forecasts and LNG demand, with the ETF positioned as a tactical trading tool amid price swings around $3/MMBtu. The overall technical signal is bullish, but oscillators remain neutral, indicating potential near-term consolidation.
The outlook for KOLD is tied to natural gas price volatility, with opportunities for short-term gains if gas prices decline due to rising supply or milder weather. Key risks include unexpected demand spikes from heat waves or geopolitical events, which could pressure the inverse ETF. Investors should monitor EIA storage reports and weather trends closely, as these are primary catalysts for movement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
